Cosmetic Peptides

Cosmetic peptides are short amino acid sequences that interact with skin cell receptors, extracellular matrix proteins, or neuromuscular signalling pathways to produce measurable improvements in skin structure and appearance. Unlike synthetic retinoids or chemical exfoliants, peptides generally achieve their effects through receptor-mediated biological signalling rather than chemical disruption — giving them excellent tolerability profiles even for sensitive skin types.

The science of cosmetic peptides is grounded in the observation that collagen degradation fragments (matrikines) act as feedback signals to fibroblasts. When collagen breaks down, small peptide fragments are released that signal the need for new collagen synthesis. Synthetic matrikines can exploit this feedback loop to stimulate collagen production without actual collagen destruction. Matrixyl (palmitoyl-pentapeptide-4) was the first cosmetic matrikine to achieve widespread commercial adoption, and double-blind clinical studies showed it reduced the depth of wrinkles by up to 33% over 12 weeks.

Argireline (acetyl hexapeptide-3) pioneered the concept of topical neuromuscular peptides for wrinkle reduction. By partially inhibiting the SNARE protein complex required for neurotransmitter vesicle fusion, Argireline reduces the amplitude of muscle contraction at facial expression sites — producing a modest Botox-like effect without injection. SNAP-8 (acetyl octapeptide-3) extends Argireline's sequence to include additional SNARE-complex interaction points, and clinical data suggests it reduces wrinkle volume by up to 63% at 8% concentration.

GHK-Cu (copper tripeptide-1) occupies a uniquely comprehensive position in cosmetic peptide science. Beyond its cosmetic collagen-stimulating effects, GHK-Cu has been shown in gene array studies to restore the expression of hundreds of genes associated with tissue repair, antioxidant defence, and anti-inflammatory signalling. GHK-Cu concentrations in blood plasma decline significantly with age, and topical or low-dose systemic supplementation may partially restore these signals.

Syn-ake and leuphasyl represent the second generation of neuromuscular cosmetic peptides. Syn-ake mimics the temple viper venom component waglerin-1, blocking sodium channel activation at the motor end plate. Leuphasyl acts as an enkephalin receptor modulator to reduce neuromuscular signalling amplitude. In UK cosmetic dermatology, the entire cosmetic peptide category falls outside MHRA medicinal regulation — they are regulated under the EU Cosmetics Regulation (retained in UK law post-Brexit) as cosmetic ingredients rather than active pharmaceutical ingredients.